CN101596215A - The application of bioactive glass compositions in anti-inflammatory and antimicrobial - Google Patents
The application of bioactive glass compositions in anti-inflammatory and antimicrobial Download PDFInfo
- Publication number
- CN101596215A CN101596215A CNA2009101395356A CN200910139535A CN101596215A CN 101596215 A CN101596215 A CN 101596215A CN A2009101395356 A CNA2009101395356 A CN A2009101395356A CN 200910139535 A CN200910139535 A CN 200910139535A CN 101596215 A CN101596215 A CN 101596215A
- Authority
- CN
- China
- Prior art keywords
- bioactivity glass
- glass
- compositions
- microgranule
- bioactivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Can effectively shorten healing time; reduce synulotic incidence rate; improve dermatoplastic success rate; reduce inflammatory response and for the patient of needs provides antibacterial therapy, comprise little non-interconnective bioactivity glass microgranule or highly the compositions that is used for the treatment of wound and the method for poroseization bioactivity glass are disclosed.Compositions comprise separately or with the non-interconnective bioactivity glass microgranule of antibiotic substance and/or anti-inflammatory substance combination.Said composition comprises the carrier that is applicable to local application.By little bioactivity glass microgranule or poroseization bioactivity glass are incorporated in the embedded material, embedded material can be by the attached anti-microbial property that gives, for example auxiliary implant, suture, die, screw, thin plate, pipe etc.Be used for exsomatizing or the cell in vitro culture apparatus by non-interconnective bioactivity glass microgranule is incorporated into, also can attachedly give these device anti-microbial properties.The bactericidal composition of obtaining from the bioactivity glass water extract is also disclosed.These compositionss can be used for, and food preparation for example is used for the solution of cell culture, and buffer is for example in the i.v. solution.
Description
The application is to be JIUYUE in 1999 10 days, denomination of invention the applying date be the dividing an application of the application for a patent for invention of " application of bioactive glass compositions in anti-inflammatory and antimicrobial ", the Chinese patent application of original application number is 99813123.7.
Technical field
The present invention relates to comprise the compositions of bioactivity glass, the water extract that obtains from these compositionss contains the cosmetics of these compositionss, contains the implant of these compositionss, and utilize these compositionss to go to promote healing, reduce the method for inflammation and bacterial infection.More particularly, the present invention relates to contain the microgranule of bioactivity glass, randomly comprise one or more and help to transport and distribute these microgranules that the compositions of the material of other therapeutical effect is also arranged simultaneously, and to the application process of these compositionss.
Background technology
When injury took place, primary cellular defect originated in the generation of emergency, for example hurt, and the result causes cell rupture, and blood capillary and other blood organ are badly damaged or are squeezed.Then, reply the infringement that can take place subsequently owing to the growth of antibacterial or owing to inflammation.
Agglutination comprises several steps, comprises blood coagulation, the reparation of inflammation, damaged tissues (or fibrous tissue formation), and blood vessel is lived again (or vascularization once more), and epithelium forms and model more again.Have in these steps several, though for promoting that normal healing is essential, if not controlledly may cause scar hyperplasia and other health related problems.
For example, not controlled scorching disease may be brought harmful consequence.For instance, many chronic even fatal diseases, such as asthma, rheumatoid arthritis, pulmonary fibrosis, peritoneal adhesion, allergy and autoimmune disease are certain not a kind of results of controlled inflammatory response.A kind of pulmonary's scorching sick (for example pneumonia) that is caused by bacterial infection may finally be caused the histologic lesion and the chronic pulmonary abscess that enlarge if do not solve.The adhesion that the inflammation of peritoneal cavity and abdominal surgery cause is a sterile main cause of women.Asthma is a kind of common fatal disease, the inflammatory response that the stimulation that it is not noted by pulmonary causes and causing.
Certain over-drastic inflammatory response may make swelling enlarge, and it may cause the additional injury as the anoxia result.Pain be by the effect of kassinin kinin and lysozyme and swelling to nerve not these factors such as pressure of the tip merge the result who causes.Not controlled inflammatory response can form a neural feedback ring and cause the too much pain sensation promptly to injure the phenomenon that area on every side still keeps pain.Therefore, the development anti-inflammatory substance has great interests for the world of medicine.
The quantity of site of injury bacterial infection is the key factor that influence recovers from injury and closes, and especially for skin ulcer, the formation of some bacterial clumps is inevitably, even may be favourable for the immunne response that stimulates the body nature.Yet too much bacterial clump obviously is deleterious and can causes high-caliber antibacterial refuse, and chronic inflammatory disease and serious transudate increase tissue necrosis and finally infection fully.The bacterial population of bearing when every gram tissue is higher than about 10
5Wound generally can not heal during individual microorganism.
Partial antimicrobial material includes the special antibiotic of body, and for example bacitracin and silver-colored sulfadiazine typically are applied to the treatment of wound.Yet it is faint relatively that these materials generally are considered to effect.The more important thing is that the microbial strain system that these materials are developed immunity to drugs increases recently, has caused many reluctant infection conditions.Antimicrobial material that other typical case uses makes as iodine and ethanol, damages natural tissue and repair cell and blocks the agglutination of skin trauma.
The therapeutic scheme of many treatment wounds and accelerated wound healing is suggested.Usually, these therapeutic schemes relate to the employing somatomedin, for example platelet derived growth factor (PDGF) or from utilizing the obtained cultured cell of trauma patient self skin.These methods are owing to prepare the difficulty of somatomedin, prepare the expensive of the time loss of cell culture and such Therapeutic Method and are restricted.And now such therapy whether have relevant potential side effect to be still unknown, for example, the life-time service corticosteroid can be accompanied by deleterious side effect.
Provide the treatment wound particularly to treat patient's bacterial infection and the compositions and the method for inflammatory response will be very useful.The present invention just provides such compositions and method.
Summary of the invention
Disclose effective shortening healing time, and stoped the compositions and the method for body nature system of defense treatment wound out of control.These compositionss are compared with method with other compositions with method and are made wound shorten healing time effectively.Inflammation around the injury greatly alleviates.Cicatrization rate after wound or the burn reduces.Also reduce the existence of antibacterial, increased dermatoplastic success.
These compositionss comprise the non-bioactivity glass microgranule that interlinks separately or with certain other antibiotic and/or anti-inflammatory substance combination, and randomly comprise the material that other is used for the treatment of.Include these compositionss, make up separately or with certain suitable carriers, the preparation that is preferably used for topical is also open here.Antiseptic solution and the methods for making and using same thereof obtained from bioactivity glass are also disclosed simultaneously.
These compositionss can be impregnated in the embedded material, for example repair implant, suture, die, screw, thin slice, pipe or the like, thus give the performance of the antibiotic and anti-inflammatory of these materials.Also can give these device anti-microbial properties by compositions being mixed the device that is used for stripped or cultured cell in vitro.
Will obtain antibiotic and anti-inflammatory composition from the water extract of bioactivity glass can be by being placed on bioactivity glass in certain aqueous solution, allow glass be dissolved to one suitable period therein, week or longer for example, then undissolved glass granules is filtered out and obtains. also solvent evaporation can be fallen, obtain having the solid material of antibacterial properties.These compositionss can be used for those and prevent or reduce bacterial infection will to be favourable place, for example, the additive of food, cosmetics are used for the medium of cell culture and cushion solution.
Be used for the treatment of wound in the part or when burning, make wound or burn and expect that the compositions of the effective dose used contacts.When being used for skin transplantation, comprise the compositions of bioactivity glass or be used in and place on the donor tissue transplanted sites before, perhaps be used in donor tissue itself.
These compositionss can be applied to pulmonary system, and for example, via an inhaler, they can be used as the auxiliary treatment means of treatment pneumonia or chronic sinus infection.These compositionss also can be applied to pulmonary system with material jointly with the treatment that itself can cause inflammation, and the inflammatory response that makes these materials cause minimizes.These compositionss can be directly used in surgical sites minimizes postoperative adhesion, makes that inflammation minimizes around the site, and prevents or make the minimum infection in this site.In one embodiment, compositions is comprised in the polymeric material, in preferably a kind of biodegradable polymeric material, is applied to surgical sites then so that postoperative intestinal adhesion minimizes.
The specific embodiment
Disclose effective shortening wound healing time and stoped the compositions and the method for body nature system of defense treatment wound out of control.Compare with other situation, these compositionss and method make wound shorten healing time effectively.Wound inflammation is on every side greatly alleviated.Follow wound or burn cicatrization rate afterwards to reduce.Also reduced the existence of antibacterial.Increased dermatoplastic success.
These compositionss comprise the non-bioactivity glass microgranule that interlinks separately or with certain other antibiotic and/or anti-inflammatory substance combination, and randomly comprise the material that other is used for the treatment of, include these compositionss and certain suitable carriers, the preparation that is preferably used for topical is also open here.Antiseptic solution and the preparation and methods for using them thereof obtained from bioactivity glass are also disclosed simultaneously.
Be not limited to any specific principle or mechanism, the absorption hydrogen ion raises the pH value in the environment with release sodium from certain solution thereby the surface area of micronized bioactivity glass and reactivity are considered to provide.By the pH value dependency combination of hemoglobin, the amount of the oxygen at the wound or the place of burning thereby be improved.
These reactions also form higher negative surface charge and have developed the absorption collagen fabric at glass surface, and the surface area of the high special of fibronectin and cell (for example can be from 0.5m in 12 hours
2/ g is initial until surpassing 50m
2/ g). and, bioactivity glass impels the calcium ion and the phosphate radical that exist naturally in wound fluid and the blood to form precipitation, thereby form the calcium phosphate layer rapidly, and the calcium phosphate layer can incorporating collagen, fibrin and fibronectin, and wound is also settled out fast effectively. in addition, bioactivity glass is considered to suppress to be present in active excessive inflammatory response in the chronic trauma consumingly, in some instances, be used in the wound of compositions disclosed herein and method healing or burn when healing even the necessity that does not have eschar to form. that is to say, new epithelial tissue can directly form, the compositions that comprises bioactivity glass described herein shows when being injected in the mouse peritoneum chamber and improves IL-6 concentration, but do not follow the rising of other cytokine, TNF-α for example, the shortage of IL-1 and other cytokine of IL-10. shows that this whole replying is an antiinflammatory rather than short scorching.
Term " wound " and " burning " are used as " damage " here jointly and mention, and their common implications are arranged, " normally " uses on it applies to this meaning of medical domain usually. and the meaning that term " antibiotic substance " and " antibiotic " are here used is meant acceptable synthetic or natural materials on the materia medica, their destroy or suppress microorganism, have both comprised that antibacterial also comprised antiviral substance. and " medical science practitioner " refers to the people that has general technical ability in wound and burn treatment field. and typically this people is doctor, nurse, dentist or nursing staff.
I. the compositions that comprises bioactivity glass
Comprise separately or can be applied to multiple purpose with the compositions of the non-interconnective bioactivity glass of antibiotic substance or anti-inflammatory substance combination.
Here to refer to a kind of main component be Si oxide for the term of Cai Yonging " bioactivity glass " or " biologically activated glass ", and a kind of inorganic glass materials that can combine with the tissue in the growth when reacting with physiological liquid.
Bioactivity glass is very familiar to those skilled in the art, and be disclosed, for example, write at L.Hench and J.Wilson, be published in 1993, WorldScientific, in the bioceramic introduction on the New Jersey (An Introduction toBioceramics), the content of the document is introduced into for referencial use thus.
Described glass preferably includes weight and accounts for 40% to 86% silicon dioxide (SiO
2), the sodium oxide (Na of about 0 to 35% weight ratio
2O), the phosphorus pentoxide (P of the calcium oxide of about 4% to 46% weight ratio (CaO) and about 1% to 15% weight ratio
2O
5). more preferably, this glass comprises weight and accounts for 40% to 60% silicon dioxide (SiO
2), the sodium oxide (Na of about 5% to 30% weight ratio
2O), the calcium oxide of about 10% to 35% weight ratio (CaO), the phosphorus pentoxide (P of about 1% to 12% weight ratio
2O
5). these oxides can exist with solid solution or blended oxide, or exist as hopcalite.
Except silicon, sodium, phosphorus and calcium oxide, CaF
2, B
2O
3, Al
2O
3, MgO and K
2O also can be contained in the compositions. preferred B
2O
3Scope be that weight ratio is from 0 to 10%. preferred K
2The scope of O is that weight ratio is from 0 to 8%.The scope of preferred L gO is that weight ratio is from 0 to 5%.
Antimicrobial salt is AgNO for example
3, the antimicrobial salt of CuO and ZnO or other argentiferous, copper and zinc ion, for example nitrate, acetate or the like can be added into. and these salt preferred range are that weight ratio is from 0 to 5%.
Most preferred glass is
(trade mark of Florida university), the compositions that it has comprises weight and accounts for about 45% silicon dioxide, the na oxide of about 24.5% weight ratio, the calcium oxide of the phosphorous oxides of about 6% weight ratio and about 24.5% weight ratio. another kind of preferred material is a hydroxyapatite.
Granular in the present invention non-interconnective bioactivity glass is preferred, that is to say, glass is to be in little isolating graininess, rather than the fusion substrate of microgranule or glass fibre are linked to be mesh or textile-like (that knot or non-knotting). note may trending towards abutting against together because of static or other external force at some condition separating particles of the present invention, but still it is interconnective to be considered to right and wrong. preferably, particle size should be less than about 90 microns; More preferably, should be less than about 20 microns; Even more preferably, should be less than about 5 microns, ideal particle size is should be less than about 2 microns when measuring with SEM or laser scattering technology.
Compare with the atresia bioactive glass compositions, highly the bioactivity glass of the poroseization antibiotic and antiinflammatory performance similar to the small particle of bioactivity glass owing to its fast relatively degradation rate and high surface area have.When highly the bioactivity glass of poroseization is used to the small particle of alternative or additional bioactivity glass, the size in hole is between about 0 to 500 μ m, preferably should be from about 10 to 150 μ m, more preferably between about 50 to 100 μ m. the porosity degree of glass is between about 0 to 85%, preferably should be about 30% to 80%, more preferably between about 40% to 60%. foraminous bioactivity glass can be produced, but for example the material by mixing certain filtering in bioactivity glass and then with the filtering from glass of this material.But suitable filtering material is familiar with to one skilled in the art, comprise, for instance, but but as sodium chloride and other water soluble salt. the granularity of filtering corpuscle roughly is the size that finally forms the hole. the relative quantity of filtering material and big I improve the porosity degree. here also be described to porosity can by employing fire obtain and/or hole by control glass Gel Treatment cycle control material and hole between obtain.
Glass composition can prepare by several modes, as the glass that provides fusing to obtain, the glass that colloidal sol is obtained and the glass granules that is fired into. the microgranule of firing can be in colloidal sol, obtain or reaction before the form that obtains of fusing. the glass that colloidal sol is obtained generally is to synthesize an inorganic network by mixed metal alkoxide in solution, by hydrolysis, gelation and low temperature (about 200 to 900 ℃) heating is produced glass and is prepared subsequently. and the glassy phase that glass that glass that the known colloidal sol of producing is in this way obtained and fusing obtain or porous fusing obtain relatively has the surface area of initial high special. and the surface area of the glass that colloidal sol is obtained has about 50m at least
2The glass that/g. fusing obtains normally passes through the granule of mixed oxide or carbonate, then at high temperature, between about 1250 to 1400 ℃, melting typically and make these mixture form homogenate and prepare. molten glass can porous and is pulverized and produce little granular materials.
Preferably fusing mode of glass composition obtains. in each preparation process, should preferably adopt SILVER REAGENT glass, particularly because use this glass to prepare the material that finally can be applied to the patient.
The glass that A, fusing obtain
The glass composition that fusing obtains can prepare like this, for example, preparation is used to prepare each metal-oxide of glass composition and the admixture of other composition, these admixtures are mixed, melt these admixtures, cooling mixture then. fusion temperature depends on glass composition to a great extent, its scope, for instance can be from about 900 ℃ to 1500 ℃, preferably about 1250 ℃ to 1450 ℃. preferred mixed melting thing, for instance, by aerating oxygen, guarantee that each component blendes together homogenate fully.
Mixture can be cooled, for instance, be added in the appropriate liquid by the admixture that will melt, deionized water for example, thereby produce glass orifice. the formation of hole can be by being crushed into powder glass, powder is mixed with foam, then at these mixture of hot extrusion under vacuum and the high temperature. the granularity of glass powder is between about 2 to 70 μ m, vacuum is preferably less than 50Mpa, hot extrusion is preferably carried out in being higher than 400 ℃ temperature, preferably between about 400 to 500 ℃, the suitable foam agent comprises the chemical compound of release of carbon dioxide at high temperature and/or water, for instance, as metal hydroxides, metal carbonate, and peroxide, hydrogen peroxide for example. preferred metal carbonate is a sodium bicarbonate, sodium carbonate and calcium carbonate. preferably with between the about 1-5% that accounts for glass powder weight, more preferably scope adds foam between 2-3%. the description of the preparation process of the porose glass that fusing obtains, for instance, be found in Ducheyne and E1 Ghannam, in the United States Patent (USP) 5648301, its content is cited for referencial use here.
B, the glass granules of firing
Glass can adopt known methodology to fire. in one embodiment, forming for example water slurry of polyvinyl alcohol of glass powder and foam and suitable bonding. outstanding solution is injected in the mould, dry, at high temperature fire then, these range of temperature depend on used glass composition and foam, between about 500 to 1000 ℃. and more preferably be between about 600 to 800 ℃.
The fiberglass that C, colloidal sol are obtained
Yet thereby the hole and the pitch of holes that are known in the art control glass gel heat treatment cycle control material produce porose glass material., because the bore dia that adopts this method will obtain greater than 0.1 micron is difficult, so in general firing of here describing be preferred with foaming process.
The leaching of D, porose material
In order to help the highly foraminous glass composition of preparation, glass composition can comprise a kind of material that can preferably sweeten off from glass composition, and make compositions that high porosity be arranged by doing like this. for instance, can be at suitable solution, the granule of dissolved material can mix with glass or is melted in the glass and sweetens off subsequently in acid or the alkali. and the hole that finally obtains microgranule similar and that leaching goes out has identical size. and be under the situation of a part of the glass composition obtained of fusing at certain material, the size in hole and degree of porosity depend on the amount of the material that adds with respect to amount of glass. for instance, if the material that leaching goes out accounts for about 80% of glass, glass will be near 80% poroseization when material is sweetened off so. when the leaching glass composition, should note will not bringing bioactive those component leachings of glass and fall, for example the oxide of calcium and phosphorus.
II. the preparation that contains bioactivity glass
Bioactivity glass can be made partial pharmaceutical preparation and be applied to wound, for example with suspension, and lotion, cream, the form of ointment or gel. those skilled in the art will be appreciated that the carrier of the topical that other is suitable for, for example listed those on U.S.P.D.
Other therapeutant
Except that bioactivity glass, can also comprise other therapeutant, for example antibiotic in the preparation, antivirin, healing promotes material, anti-inflammatory substance, immunosuppressant, somatomedin, antimetabolite, cell adhesion molecule (CAMs), BMP (BMPs), angiogenesis material, anticoagulant and local anesthetic/analgesics.
Antibiotic can be the local antibiotic that is fit to skin treating. so antibiotic example is including, but not limited to following antibiotic: chloromycetin, chlortetracycline, clindamycin (clyndamycin), nioform, erythromycin, framycetin, Gramicidin, fusidinic acid, gentamycin, homosulfamine, mupirocin, neomycin, polymyxin B, bacitracin, silver sulfadiazine, tetracycline and chlortetracycline.
Suitable antivirin comprises the topical antiviral element, for example acycloguanosine and ganciclovir. suitable anti-inflammatory substance comprises corticosteroid, uncle's d ritalinic acid hydrocortisone and nonsteroidal antiinflammatory drug.Suitable somatomedin comprises basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), transforming growth factor and β (TGF α and β), platelet derived growth factor (PDGF) and VEGF/vascular permeability factor (VEGF/VPF).Suitable local anesthetic comprises benzocaine and lignocaine.
In one embodiment, therapeutant is a kind of material that if not can cause inflammation on its release site, and the bioactivity glass microgranule alleviates relevant inflammation.For instance, chemical compound lot, aminated compounds for example during topical, can cause inflammation in transdermal pastes when being used to local application. and many other chemical compounds when promptly using via an inhaler, can cause inflammation when via the lung administration.
Need not any carrier or excipient and granular bioactivity glass is placed directly in the wound face or one be feasible on burning. preferably any medical acceptable carrier that is used for local application separately the mixed biologic activity glass or with the bioactivity glass of one or more other therapeutants combinations, suspension for example, ointment, cream or gel, thereby help being administered on the wound. for instance, compositions of the present invention can be mixed the formation ointment with white vaseline, form suspension with mineral oil, form non-oils and fats cream with certain commercial available white class cosmetic base, or commercial available water miscible with certain, lubricating gel for example KY Gel (trade mark) forms high water quality gel.
Bioactivity glass and other therapeutant can combine with other wound and burn treatment articles for use or dressing, such as, but be not limited to, collagen, fibrin, fibronectin, various somatomedin are PDGF for example, TGF-β, vitamin E, gauze, Cotton Gossypii, cellulose, synthetic wound or burn dressing and other well known to a person skilled in the art wound or the dressing/treatment articles of burning. fibrous glass dressing, comprise that the fibrous glass of making from the fiber of bioactivity glass also can be employed. in addition, bioactivity glass can combine with any biocompatible materials, the biological example degradable polymer, such as with polylactic acid/glycolic, form a kind of composite that promotes wound healing.
And the ratio of bioactivity glass and carrier is not crucial, and preferably the mixture of bioactivity glass and other therapeutant and carrier comprises approximately from 20% to about 80% bioactivity glass.The particle size scope of preferred bioactivity glass it is introduced and is not more than about 90 microns. specifically, particle size less than about 10 microns with equally also can be employed less than about 2 microns, these particle size are to adopt SEM or laser scattering technology to measure, the microgranule of so little size range generally provides advantage of the present invention, but do not stop any deleterious immunne response. this phenomenon is the result of non-expectation, in view of the routine of replying of the biology of finding in the literature to little synthetic microgranule.The variation of the ratio of other therapeutant is relevant with the character of application and material.Yet preferred ratio is such, promptly be applied to wound or the amount of substance of burning should be with the time with the medical treatment of standard acceptable scope of medication consistent.
If bioactivity glass and topical carrier, mutually blended words of ointment for example, so preferably important pre-reaction did not take place in glass before using. and this point can be accomplished, for example, by set of applications compound immediately after mixing. in other words, topical carrier can have a kind of like this character promptly not with glass generation pre-reaction, for example, glycerol for instance. biological activity bead glass and topical carrier can be the systems that component separately is arranged in two parts, wherein bioactivity glass and topical carrier are mixed and be applied simultaneously. for instance, can use the mixed syringe of a kind of two parts that have 2 storerooms that separate and a mixing chamber. and other two parts system also can adopt.For instance, the biological activity bead glass can be impregnated in the binder and to wound or burn and use topical carrier, bind binder subsequently. and it is known to those skilled in the art that other two parts send delivery system.
III. the goods that comprise bioactivity glass
These compositionss can be incorporated in the implant material, for example prosthetic implant, sheet, bolt, valve, suture, die, screw, thin slice, pipe etc., by mixing in the material that the bioactivity glass microgranule enters implantation, these compositionss can be with the model casting or make of machine.
In another embodiment, by bioactivity glass non-interconnected microgranule mix be used in the device exsomatizing or the cell in vitro culture apparatus with anti-microbial property.
Goods are given anti-microbial property by mixing of bioactivity glass, thereby allow these article implanted or be used for cell culture, have reduced the probability of bacterial cross-infection.
IV. the aqueous solution of obtaining from bioactivity glass
The method that the compositions of antibacterium (and antifungal) obtains from the water extract of bioactivity glass is that bioactivity glass is placed in the aqueous solution, allow glass one suitable period of dissolving, the undissolved glass granules of filtering then. the solid material to provide to have anti-microbial property can be provided solvent. and these compositionss can be used to antibacterial where, for instance, food additive, the solution that is used for cell culture, and buffer solution.
Be not entangled in a certain special principle, the relation of a complexity is considered to be present in the ionic type that is released from glass, ionic quantity and release incidence rate, solution pH value and final antimicrobial or antiinflammatory are replied among these problems. and this effect reaches at bioactivity glass microgranule self and all can observe from the solion that glass granules is obtained. therefore, in the application that is described below, the bioactivity glass microgranule can be used to replace or make an addition to the solution of obtaining from microgranule.
Food additive
Numerous foods may be by for example E.coli infection of antibacterial. is subjected to bacterial infection especially easily with Carnis Gallus domesticus in the cattle of pulverizing. and the aqueous solution of the water extract that obtains from bioactivity glass has anti-microbial property, as described in the following embodiment 3, antibacterial effect depends in part on the alkaline nature of solution, and (PH is greater than about 7, be preferably more than about 9, more preferably greater than about 10.5) yet., sodium hydrate aqueous solution with high relatively pH value is ineffective in sterilization. and therefore, the aqueous solution with extra antiseptic elements is better than only having the solution of high relatively pH value.
Compositions can be sprayed on surfaces contaminated, or is incorporated into food product, since in for example pulverizing in the cattle. and bioactivity glass is confirmed to can be used for multiple use by FDA, and the extract of bioactivity glass should be harmless to the mankind so.
Cosmetics
The cosmetics of fluid matrix, skin lotion for example, shampoo and hair rinse agent, directly applying to people's skin. it is when product is in the container of sealing that yet present manufacture process is generally controlled germ contamination, after unpacking, antibacterial, fungus and/or mycete may pollute cosmetics. and usually, various antibiotic substance are added in the cosmetics so that this pollution course minimizes.
These compositionss can be incorporated into and make antibacterial in the cosmetics, the minimum contamination of fungus and/or mycete. compositions can be added into, for instance, in the cosmetic base, liquid foundation for example, shampoo, hair dye, lip pomade, skin lotion, emulsion, white class and other. can comprise solion described herein and/or bioactivity glass microgranule described herein in the cosmetics.
Solid composite
Aqueous solution can be dried provides a kind of bactericidal composition, for instance, and by spray drying or vacuum drying.Compositions can be incorporated in other germicidal solution, for example
Provide extra antimicrobial component for solution in the solution.
Cell growth and cultivation
Have many solution to be used for cultured cell. these comprise Dulbecco ' s MEM, Hank ' s balanced salt solution and other. these solution must with oozed by cultured cells etc. problem common in the cell culture is to be attended by bacterial growth in the conceivable cell in cultivation. the growth of antibacterial can be minimized by mix the bioactivity glass extract in cell culture medium.
Buffer solution
Buffer solution, for example HEPES and TRIS, often be in the optimal pH of support bacteria growth. add the bioactivity glass extract and in compositions, will give the solution anti-microbial property, and the antibacterial effect of extracting solution depends in part on high relatively pH value, lower pH value is also effective a little. as shown among the embodiment 3, as a kind of antiseptic solution in addition pH be 7.6 o'clock generally also effective.Therefore, although the buffer pH value is low slightly, this solution will show anti-microbial property. in one embodiment, buffer solution is a kind of I.V. solution, for instance, phosphate buffer.
V. promote the method for wound healing
The bioactivity glass microgranule can greatly reduce the essential time of wound healing. and, containing and non-ly interconnect bioactivity glass microgranule (or comprising the highly implant of poroseization bioactivity glass) and the compositions of other antibiotic substance can increase the normal healing process. the effectiveness of compositions is presented at immunocompromised patient the most highlightedly, promptly on the downtrod slightly person of the ability of healing wounds.
In present clinical practice, compositions can be applied to wound or burn by the mode similar with topical formulations. and the definite amount of application is by medical practitioner's decision, but typical application is at least once compositions to be sprinkled upon on the predetermined area and to put around thin film in general one day. use after the compositions, injury adopts acceptable medical convention to handle. for example, after the set of applications compound, injury is typically used aseptic bandaging, the patient can be applied antibiotic, the pharmacotherapy of analgesic and/or other whole body. the treatment of injury is successive, up to judgement through medical practitioner, wound heals, when further treatment there is no need till.
Cause effective wound healing or provide the method for wound antibacterial therapy to comprise, optionally combine with a kind of other antibiotic or anti-inflammatory substance with the non-bioactive glass particle contact wound that interconnects that effectively promotes wound healing or antibiotic amount.
In one embodiment, chemical compound is used to filling cavity, be included in the cavity that produces in the medical procedure. for example, boring the tooth of opening in the operation of root of the tooth pipeline can fill with the compositions that comprises bioactivity glass. and this will help to prevent that bacterial infection from filling at last until tooth. and the compositions that comprises bioactivity glass also can be used to fill the cavity that may occur between tooth and the gingiva. and the compositions that comprises bioactivity glass can be used for filling the cavity that hemangioma exists, and prevents bacterial growth in the cavity of filling.Other cavity that can be filled comprises those cavities that surgical operation forms, for example excision of spleen, ovary, cholelithiasis or tumor.
VI. the method for cutify
The method of cutify comprises non-interconnective bioactivity glass microgranule was administered on the transplanted sites before placing donor tissue, perhaps is administered to donor tissue itself.
The method of cutify is included in donor tissue and is placed on and micronized bioactivity glass is administered to transplanted sites or donor tissue before the precalculated position. those to dermatoplastic detailed description is interested can be with reference to skin transplantation " Skin Grafts "; be published in Selected Readings in plastic Surgery in 1992; Vol.7; No.2; P.L.Kelton; MD, Baylor University Medical Center. also can be with the further grafts of topical carrier before transplanting. and the application of bioactivity glass in transplanting is considered to improve the probability that graft was accepted and mixed host's main body.The bioactivity glass microgranule serves as the role of middle junction zoarium between host and transplanted tissue, inhibition may cause total inflammatory response of repelling, quickens to cause faster total agglutination of more successfully accepting transplanted tissue simultaneously.
VII. improve the outward appearance of scar tissue and the method for structure
The scar tissue that forms when being used to improve wound healing is the outward appearance of keloid tissue and the method for structure particularly, relates to the non-microgranule that interconnects of bioactivity glass that can effectively improve cicatrix outward appearance amount contacting with it when wound healing.In this method, microgranule preferably is present in the aseptic treatment acceptable carrier, for example ointment or gel.
Can change the formation of scar tissue by at least two kinds of mechanism in the existence of the site of injury bioactivity glass microgranule that is just healing. at first, bioactivity glass is by adsorbing for example prostaglandin of inflammation neutretto, TNF-α, the IL-1 and the various kinds of cell factor and discharge and can cause the high ion of born of the same parents' exosmosis voltage rise and work and reduce whole inflammatory responses. the inflammatory response that has reduced will reduce the quantity and the activity of macrophage and other inflammatory cell, discharge the concentration of removing to replenish fibroblastic chemotactic factor thereby reduce. and reducing the active final result of the fibroblast that gets off from the overacfivity level is the reduction of scar tissue density.
Secondly, bioactivity glass attract and the incorporating collagen fiber to their surface. they move along with glass granules and along microparticle surfaces and construct collagen from the teeth outwards when fibroblast is infiltrated wound. the random distribution of the bioactivity glass microgranule of attraction and incorporating collagen fiber will determine fiber oneself orientation at random. when glass granules disappears when molten, they have stayed the collagen fiber substrate of a random orientation, and its mechanical performance is more mated with those unscathed tissues.
Other benefits of utilizing said method treatment wound and cutify are can more identical with surrounding skin and more mate at the scar tissue that healing place forms. like this, scar tissue, its formation generally is inevitably, can have an outward appearance preferably. and this benefit is even more important with burning for the facial wound of treatment. and the present composition also can be used for improving when wound or burn synulotic outward appearance and structure when healing.
VIII. the method that reduces inflammation
Compositions can be used to alleviate patient's inflammation. and excessively acute or chronic inflammation can cause the patient to be in various disease states, and for instance, arthritis and tenosynovitis, pulmonary disease are for example panted and edema due to disorder of QI, and (peritoneum) adhesion behind the surgical operation.
Very little microgranular bioactivity glass has the performance that can bring into play antiphlogistic effects when contacting with bodily tissue. and as if the earliest stages bioactivity glass of using at bioactivity glass just suppresses the generation of tissue tumor necrosin ﹠ (TNF-α) and interleukin (IL-1). and this effect is of short duration and does not reduce the immunne response of any subordinate. this point and use somatomedin, antibiotic or other cytokine are different fully, use somatomedin, antibiotic or other cytokine all show the influence to the immune system subordinate, even they may be very little.
TNF-α is that strong inflammatory cytokine is former, it not only participates in normal inflammatory response, the same ischemia one heavy perfusion of also participating in other inflammation disease receptor damages, septicopyemia, morbus cardiacus, viral myocarditis and caused myocardial dysfunction of allosome heart transplantation repulsive interaction and myocardial necrosis. therefore, by suppressing the generation of TNF-α, compositions has reduced the probability that these diseases take place.
The magnitude range of preferred bioactivity glass is such in this embodiment, be microgranule can actual occluding vascular by health the time, lymphatic vessel or pulmonary passages. size is particularly preferred less than 20 microns microgranule when measuring with SEM or laser scattering technology, because immunochemistry result shows health and can not resemble other microgranule that for example silica microparticle produces these microgranules like that and replys. experiment is presented at
The gathering of macrophage improper or protuberance does not appear in the injected local body of microgranule. and the small particle of this and other material forms completely and contrasts, for example Pulvis Talci, asbestos, siloxanes and metal fragment, they are known to be strong inflammation originality.
Do not plan to be entangled in any special principle or mechanism; it is believed that it is the high surface and the reactive release that sodium, calcium, phosphorus, silicon and other ionic species of solubility are provided of micronize bioactivity glass. ionic environment is accompanied by the pH value of rising; it is believed that it is that the such paths of statement of the cell neutretto by influencing important inflammation works. in addition, neutrophil, macrophage and other immunocyte can be drawn the non-antiphlogistic effects of expecting with direct contact of microparticle surfaces on cell function.
Antiinflammatory bioactivity glass microgranule is incorporated in the compositions of preparation by pulmonary transportation therapeutant, and this to be incorporated in when causing inflammation in lung after those substance be favourable.
The local inflammation result, for example those to utilize transdermal to be attached among some patients observed, can obtain relaxing during example gel, frost, foam, cream or transdermal paste by mixing the bioactivity glass microgranule in topical formulations.
Having done a large amount of effort goes to transport medicine through pulmonary route. and when transporting, there are several therapeutants can cause the local inflammation result. these results can minimize by mixing the bioactivity glass microgranule in the compositions that is used for pulmonary's dispenser. and in one embodiment, the water extract of bioactivity glass can be used to replace or make an addition to the biological glass granules of living to obtain same antiphlogistic effects. and aqueous solution can be used as pharmaceutical carrier in an intranasal medicine vehicle.
Bioactivity glass microgranule and/or comprise the solution of the extract that obtains from bioactivity glass can be transported to patient's inflammation site by local injection, for example, and at an inflamed joints or tendon place.
Bioactivity glass microgranule and/or comprise the solution of the extract that from bioactivity glass, obtains, can pass through intravenous, injection is transported so that the antiphlogistic effects of whole body to be provided in intramuscular or the abdomen abdomen. and these effects can have therapeutical effect and/or preventive effect, for instance, bioactivity glass and/or the system that comprises the solution of the extract that obtains from bioactivity glass transport and can reduce the initial of inflammation that external attack causes effectively.
The bioactivity glass microgranule can be locally applied to surgical sites so that postoperative intestinal adhesion minimizes. and glass granules can randomly be incorporated in the polymeric material that is applied to surgical site. preferably, this polymeric material is biodegradable, microgranule is released when depolymerization. and the polymeric material that is suitable for this purpose is disclosed, for instance, the United States Patent (USP) 5,410,016 of Hubbell etc., its content is introduced into for referencial use here. and other is suitable for this purpose material, for example
Agarose and crosslinked alginate are known for a person skilled in the art.
Highly poroseization bioactivity glass is owing to its high relatively surface area has the antiphlogistic effects identical with little glass granules.
The biological medicine implant often causes inflammation on implantation site. the bioactivity glass small particle and/or highly poroseization bioactivity glass be incorporated into implant, the surface of implant particularly, can greatly reduce the generation of the inflammation relevant with implant. this is particularly useful in suture material, the inflammation relevant with these materials minimized. discuss as following, the anti-microbial property of compositions also allows the minimum infection of suture around in the suture site.
" the effective antiinflammatory amount of bioactivity glass " refers to the amount of the bioactivity glass with suitable particle size that can effectively reduce inflammation. and those skilled in the art can pass through to pulmonary system or to the dermal administration therapeutant, see through the system that transports of skin and the definite or expection situation that alternate manner is easy to assess the inflammation relevant with wound site via one for instance, this wound site is by damage for instance, surgical procedures, arthritis or other autoimmune diseases etc. causes. those skilled in the art also can utilize this assessment to decide the amount of the suitable antiphlogistic bioactivity glass in the inflammation site that is applied to inflammation site or expection.
IX. reduce the method for bacterial infection
Yet the bulky grain of bioactivity glass and no hole bioactive glass do not have measurable bactericidal property., bioactivity glass small particle and when highly poroseization bioactivity glass is in being present in water environment, really having measurable bactericidal property. bactericidal property has shown can anti-staphylococcus aureus (Staph.aureus), staphylococcus epidermidis (staph.epidermidis) and various be common in the skin and skin on streptococcus. do not belong to a certain special mechanism of action, this effect it is believed that it is greatly to have improved the bioactive result of small particle, it can cause ambient water environment pH extremely to raise. and can broad-spectrum sterilization keep the associating performance of tissue biocompatibility to make the small particle of bioactivity glass become suitable antibacterial therapy material again simultaneously, particularly for dermatosis skin ulcer for example.
Antibacterial action improves with the reduction of particle size, preferred particle size partly depends on initial amount of bacteria and conceivable sterilizing power, for example, for general bacterial load amount with the wound that does not infect, yet the compositions less than 20 microns magnitude range is just enough., danger for higher its infection of bacterial load amount is strengthened, and compositions should comprise the microgranule of measuring by SEM or laser scattering technology less than 5 microns sizes.
" the effective antibiotic amount of bioactivity glass refers to has the amount that suitable particle size can effectively reduce the bioactivity glass of bacterial infection. and those skilled in the art can assess the bacterial load amount of a wound at an easy rate; and the suitable particle size and the quantity of the bioactivity glass that utilizes this assessment to decide to be applied to wound. when here using, term ' antimicrobial ' also is used in reference to the ability that compositions reduces the infection that is caused by fungus or mycete.
Can more ask Chu ground to understand the present invention with reference to following unrestriced example.
Embodiment
Embodiment 1: with micronized bioactive glass treatment wound in the carrier
The wound that vasculitic patient is promptly taken place after injured is soon taken photos; such wound typically requires about 3 months complete healing time. and this trauma care has adopted the non-micronize bioactivity glass that interconnects by fine particle size; local antibiotic; comprise sulfadiazine, and the mixture of vaseline medium carrier composition.
After with the bioactive glass compositions treatment, promptly first photograph taking is after 4 days, same wound has been taken second photo again, the 3rd photo of same wound taken after having clapped 7 days at second, and the 4th photo of same wound taken after having clapped 14 days at second. and these photos prove that wound healing get fine. and the wound that similarly has a vasculitic patient not expectability takes about 3 months at least and shows that just similarity degree heals.
For instance, second photo demonstrates, only after 4 kings, if the site of injury seepage stops and wound surface becomes dry. such band vasculitis patient's wound is only handled with local antibiotic, usually to spend about 2 weeks to stop seepage. the 3rd photo demonstration healing mechanism is carried out well, and only fatty tissue has covered wound surface after 11 days. the 4th photo shows only after 18, about 50% healing of wound. in having vasculitic patient, the wound of type generally will spend about 6 to 8 weeks just can reach for 50% healing stage on the photo.
The treatment of embodiment 2, diabetics delayed union
Suffer the diabetes patient of healing delay infringement to adopt micronize bioactivity glass and the equal-volume NEOSPORIN of particle size less than 40 μ m
TMThe mixture of antibiotic ointment is treated.This ointment mainly is to be the mixture of the antibiotics material of substrate with vaseline. it is long that mixture is directly used in the about 1/2cm of healing delay infringement place, 1/2cm is wide. and these infringements generally are the still disunion above 14 days, mixture one day stops with seepage within 2 times .24 hour. and wound is closed and is healed and finish within 5 days. and within 48 hours, scar tissue promptly occurs around edge of wound.
When scar tissue continued development, the typical outward appearance of the type of impairment that its outward appearance ratio is treated in this patient was more near surrounding tissue. and after the development fully, the outward appearance of scar tissue is almost near surrounding tissue.
The anti-microbial property of embodiment 3. bioactivity glass
Little micronized bioactivity glass and highly poroseization bioactivity glass have antibacterial activity. in aqueous solution; contain 45% silicon dioxide; 24.5% sodium oxide, the bioactive glass compositions of 24.5% calcium oxide and 6% phosphorous oxides make pH rise in aqueous solution.Experiment subsequently is carried out the anti-microbial property that proves final solution.
The sizes that nutrient broth (10ml) is added into 5 gram holes respectively are micronize bioactivity glass between 355 to the 500 μ m; the bead (be not bioactivity glass) of 5 gram particle size between 455 to 600 μ m; not adding bead. the solution that obtains was hatched 1 hour 37 ℃ of rotations. and each takes out among the 50 μ l S.Sanguis of 950 μ l supernatant adding incubated overnight, hatches 1 hour for 37 ℃.To count by live body and to measure the existence number. the decreased average of observing live body number in the bioactivity glass supernatant reaches 97%, and the bead supernatant is then seldom or do not have lethality (13%).
In order to determine that pH changes role, experiment repeats in the following ways: 50 μ lS.sanguis are joined unmodulated BGS (bioactivity glass solution), BGS and HCl (PH about 7.2), BGS and NaCl (pH about 9.8) (chloride ion add contrast) and meat soup (pH about 7.2). the culture that is incubated in the high pH solution shows survival rate reduction by 81% (unmodulated BGS) and 82% (BGS and NaCl), by comparison be 5% reduction rate in the BGS that HCl handled.Alkaline solution (the NaOH that experiment subsequently obtains with abiotic activity glass, pH9.8) demonstrate lower antibacterial activity, can reduce its antibacterial activity though lethality is 40%. these proof bioactivity glass supernatant pH value reductions, not all observed lethality all gives the credit to their high pH value.
The antiphlogistic effects of embodiment 4, bioactivity glass microgranule
The hyclone and the phosphate buffer 1 that comprise the 25mg bioactivity glass: the 1ml suspension of 1 mixed solution by peritoneal injection in one group 5 bull mice bodies. other one group of 5 mice accepts not have the same solution of bioactivity glass to be used as contrast. injected back two hours; the peritoneal fluid washed is checked that extra cell that the situation of leukocyte recruitment and inflammation neutretto TNF-α and IL-1. find not to be higher than control level by microscopic examination is assembled .ELISA and measured and show that TNF-α and IL-1 surpass control level .IL-6 level appropriateness and rise; but there are not observable TNF-α and IL-1 level; this has shown general antiinflammatory action. consider that the micronize material that causes strong inflammatory response in this case in addition exists really, the shortage of assembling cell and their inflammation signal is being represented the direct repression of inflammatory response.
The antiphlogistic effects of embodiment 5, bioactivity glass microgranule
A middle aged male mouse suffers from the open skin ulcer in two places at right forearm. and these wounds do not heal and the height inflammation; a large amount of transudates are arranged; the local inflammation of the open wound that bacterial clump is arranged is replied and has been caused edema and erythema. behind little micronize bioactivity glass topical therapeutic two place's wounds; all local inflammatory symptoms have stopped, and ulcer normally heals.
Claims (9)
1. bactericidal composition comprises the disconnected bioactivity glass microgranule of effective antibiotic amount.
2. the compositions in the claim 1, wherein bioactivity glass has the composition of following percentage by weight:
Composition percentage ratio
SiO 240-86
CaO 10-46
Na
2O 0-35
P
2O
5 2-8
CaF
2 0-25
B
2O
3 0-10
K
2O 0-8
MgO 0-5。
3. the compositions in the claim 1, wherein bioactivity glass has the composition of following percentage by weight:
Percentage composition
SiO
2 45
CaO 24.5
Na
2O 24.5
P
2O
5 6。
4. the compositions in the claim 1, when wherein bioactivity glass particle size scope is measured with SEM or laser scattering technology less than about 90 microns.
5. the compositions in the claim 1, when wherein bioactivity glass particle size scope is measured with SEM or laser scattering technology less than about 20 microns.
6. the compositions in the claim 1, when wherein bioactivity glass particle size scope is measured with SEM or laser scattering technology less than about 2 microns.
7. bactericidal composition comprises the water extract of the bioactivity glass microgranule of effective antibiotic amount.
8. the compositions in the claim 7, wherein bioactivity glass has the composition of following percentage by weight:
Percentage composition
SiO
2 40-86
CaO 10-46
Na
2O 0-35
P
2O
5 2-8
CaF
2 0-25
B
2O
3 0-10
K
2O 0-8
MgO 0-5。
9. the compositions in the claim 7, wherein bioactivity glass has the composition of following percentage by weight:
Percentage composition
SiO
2 45
CaO 24.5
Na
2O 24.5
P
2O
5 6。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9972598P | 1998-09-10 | 1998-09-10 | |
| US60/099725 | 1998-09-10 | ||
| US09/392516 | 1999-09-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB998131237A Division CN100528231C (en) | 1998-09-10 | 1999-09-10 | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101596215A true CN101596215A (en) | 2009-12-09 |
Family
ID=41417932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009101395356A Pending CN101596215A (en) | 1998-09-10 | 1999-09-10 | The application of bioactive glass compositions in anti-inflammatory and antimicrobial |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101596215A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908692A (en) * | 2014-03-30 | 2014-07-09 | 浙江圣兆医药科技有限公司 | Composite biological material patch and preparation method thereof |
| CN107684636A (en) * | 2016-08-04 | 2018-02-13 | 北京纳通医学科技研究院有限公司 | A kind of bactericidal composition and as the bacteria cellulose antimicrobial composite material obtained by it |
| CN107693840A (en) * | 2016-08-09 | 2018-02-16 | 北京纳通医学科技研究院有限公司 | A kind of liquid adhesive bandage and preparation method thereof |
| CN113768799A (en) * | 2021-10-19 | 2021-12-10 | 四川涑爽医疗用品有限公司 | Multi-ion mixed solution, preparation method and application thereof, and oral care product containing multi-ion mixed solution |
| CN113827485A (en) * | 2021-09-28 | 2021-12-24 | 中南大学 | Root canal filling material containing bioactive glass and preparation method thereof |
| CN114452435A (en) * | 2021-11-15 | 2022-05-10 | 浙江蓝智生物科技有限公司 | High-affinity liquid dressing capable of being rapidly effective |
-
1999
- 1999-09-10 CN CNA2009101395356A patent/CN101596215A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908692A (en) * | 2014-03-30 | 2014-07-09 | 浙江圣兆医药科技有限公司 | Composite biological material patch and preparation method thereof |
| CN103908692B (en) * | 2014-03-30 | 2016-05-18 | 浙江圣兆医药科技有限公司 | A kind of composite biological material is applied ointment or plaster and preparation method |
| CN107684636A (en) * | 2016-08-04 | 2018-02-13 | 北京纳通医学科技研究院有限公司 | A kind of bactericidal composition and as the bacteria cellulose antimicrobial composite material obtained by it |
| CN107693840A (en) * | 2016-08-09 | 2018-02-16 | 北京纳通医学科技研究院有限公司 | A kind of liquid adhesive bandage and preparation method thereof |
| CN113827485A (en) * | 2021-09-28 | 2021-12-24 | 中南大学 | Root canal filling material containing bioactive glass and preparation method thereof |
| CN113768799A (en) * | 2021-10-19 | 2021-12-10 | 四川涑爽医疗用品有限公司 | Multi-ion mixed solution, preparation method and application thereof, and oral care product containing multi-ion mixed solution |
| CN114452435A (en) * | 2021-11-15 | 2022-05-10 | 浙江蓝智生物科技有限公司 | High-affinity liquid dressing capable of being rapidly effective |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100528231C (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
| US6756060B1 (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
| Mehrabi et al. | Bioactive glasses: a promising therapeutic ion release strategy for enhancing wound healing | |
| Kargozar et al. | Can bioactive glasses be useful to accelerate the healing of epithelial tissues? | |
| Baino et al. | Bioactive glasses: Special applications outside the skeletal system | |
| Zhou et al. | Rational design of intelligent and multifunctional dressing to promote acute/chronic wound healing | |
| TWI563987B (en) | Hydrogel wound dressing and biomaterials formed in situ and their uses | |
| WO2019091150A1 (en) | Alginate wound repair dressing and preparation method thereof | |
| Shen et al. | Advances in copper-based biomaterials with antibacterial and osteogenic properties for bone tissue engineering | |
| CN101371925A (en) | Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof | |
| Yao et al. | Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects | |
| Saini et al. | Immunomodulatory properties of chitosan: Impact on wound healing and tissue repair | |
| Andleeb et al. | Developing affordable and accessible pro‐angiogenic wound dressings; incorporation of 2 deoxy D‐ribose (2dDR) into cotton fibres and wax‐coated cotton fibres | |
| Rivero et al. | Nanofibrous scaffolds for skin tissue engineering and wound healing applications | |
| CN113511811A (en) | Multifunctional mesoporous biomaterial, preparation method and application | |
| CN101596215A (en) | The application of bioactive glass compositions in anti-inflammatory and antimicrobial | |
| Issaka | State-of-the-art of synthesized exosomes and NPs-based biomimetic nanoparticles for wound rehabilitation: a review | |
| Singh et al. | Multicomponent decellularized extracellular matrix of caprine small intestine submucosa based bioactive hydrogel promoting full-thickness burn wound healing in rabbits | |
| MXPA05002589A (en) | Antibiotic microspheres for treatment of infections and osteomyelitis. | |
| RU2699362C2 (en) | Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for treating wounds | |
| Miguez-Pacheco et al. | Bioactive glasses for soft tissue engineering applications | |
| CN109432483B (en) | Medical dressing for accelerating wound healing and preparation method and application thereof | |
| TWI288646B (en) | Novel dressing materials capable of promoting rapid healing of wounded skin surfaces | |
| CN116370692A (en) | Repair material and preparation method thereof | |
| CN108452370A (en) | A kind of compound supramolecular hydrogel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20091209 |